Company: LIDRW
Filing Date: 2025-02-25
Form Type: S-1/A
Source: 0000947871-25-000219
Chunk: 25

Company: AEye, Inc.
Filing Date: 2025-02-25
Form: S-1/A
Chunk 25
---
 the Company’s Common Stock. The Note Registration Rights Agreement requires the Company to prepare and
file a registration statement to cover the resale of the Company’s Common Stock issuable upon conversion of the note and/or exercise
of the warrant. Such registration statement on Form S-3 (Registration No. 333-267937) was filed by the Company with the SEC under the
Securities Act on October 19, 2023, and declared effective by the SEC on October 27, 2023.

The Company is a party to the Dowslake Purchase Agreement entered into
in connection with a transaction pursuant to which the Company has issued to Dowslake shares of the Company’s Common Stock and a
senior unsecured convertible promissory note, convertible into shares of the Company’s Common Stock. The Dowslake Purchase Agreement
requires the Company to prepare and file a registration statement to cover the resale of the Company’s Common Stock purchased by
Dowslake or issuable upon conversion of the note.

The Company is also a party to the 2025 Registration Rights Agreement entered
into in connection with a transaction pursuant to which the Company has issued to an institutional investor a senior unsecured convertible
promissory note (the “2025 Note”), convertible into shares of the Company’s Common Stock, and a warrant (the “2025
Warrant”), exercisable into shares of the Company’s Common Stock. The 2025 Registration Rights Agreement requires the Company
to prepare and file a registration statement to cover the resale of the Company’s Common Stock issuable upon conversion of the 2025
Note or exercise of the 2025 Warrant.

| 21 |

<div align='center'>PLAN OF DISTRIBUTION</div>

We are registering the shares of Common Stock constituting
the Dowslake Shares and shares issuable upon conversion of the Securities by the holders thereof from time to time after the date of this
prospectus. We will not receive any of the proceeds from the sale by the Selling Stockholders of the shares of common stock, although
we will receive the exercise price of the Warrant exercised by the Selling Stockholders for cash. We will bear all fees and expenses incident
to our obligation to register the shares of Common Stock.

The Selling Stockholders may sell all or a portion
of the shares of Common Stock held by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers
or agents. If the shares of Common Stock are